Hellstrand lab leukemia research: exploring immune escape and defining therapeutic targets
Histamine dihydrochloride to prevent relapse in AML: development and ongoing research
iwNHL 2018 day 1 highlights: T-cells, biomarkers & personalized medicine
Catherine Bollard et al.
Checkpoint inhibitors: parallel management of the disease and immune-related toxicities
Immune checkpoint inhibitors for AML: mechanism, rationale & using azacitidine to boost response